Radcliffe Capital Management’s USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 HUGS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-133,333
Closed -$1.29M 1114
2021
Q3
$1.29M Hold
133,333
0.04% 623
2021
Q2
$1.29M Buy
+133,333
New +$129K 0.04% 647

Other funds holding HUGS.WS

Radcliffe Capital Management's HUGS.WS Position: Q4 2021 in Review

Radcliffe Capital Management sold out of USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (HUGS.WS) in Q4 2021, closing a stake of 133,333 shares — an estimated $1.29M sold.

Radcliffe Capital Management first reported a position in HUGS.WS in Q2 2021 and held it in 2 quarters. The position peaked at $1.29M in Q3 2021. 41 funds tracked by Wall St. Rank hold HUGS.WS as of Q4 2021.

  • Radcliffe Capital Management reported no remaining USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Radcliffe Capital Management sold 133,333 USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2021, an estimated $1.29M.
  • Radcliffe Capital Management first reported a position in USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2021 and held it in 2 quarters.
  • Radcliffe Capital Management's USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $1.29M in Q3 2021.
  • 41 funds tracked by Wall St. Rank held USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2021.

Based on Radcliffe Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.